Skip to main content
Erschienen in: Virchows Archiv 1/2017

24.05.2017 | Original Article

Epidermoid cysts are a characteristic feature of intrapancreatic but not of extrapancreatic accessory spleens

verfasst von: Kenichi Hirabayashi, Misuzu Yamada, Hirotaka Kono, Atsuko Hadano, Aya Kawanishi, Yumi Takanashi, Yoshiaki Kawaguchi, Toshio Nakagohri, Tetsuya Mine, Naoya Nakamura

Erschienen in: Virchows Archiv | Ausgabe 1/2017

Einloggen, um Zugang zu erhalten

Abstract

Accessory spleens (ASs), ectopic splenic tissue at intrapancreatic and extrapancreatic sites, rarely contain epidermoid cysts. Our aim was to analyze the incidence of epidermoid cysts in ASs and perform an immunohistochemical analysis of its epithelial lining. We included in the study 148 ASs from 135 patients, for which pathological data were available. Eleven were intrapancreatic ASs (IPASs) and 137 were extrapancreatic ASs (EPASs). Six of the eleven (55%) IPASs contained epidermoid cysts, but they were not detected in EPASs. Immunohistochemical analysis showed that both the superficial/luminal and basal layer of the epithelial lining of epidermoid cysts in IPASs are negative for MUC2, MUC5AC, MUC6, WT-1, calretinin, thrombomodulin, uroplakin-II, and uroplakin-III. The superficial/luminal layer was positive for MUC4, CK7, and CA19-9 in all cases (100%), for CEA and HBME-1 in three cases (50%), and for MUC1, CK5/6, and CK20 in two cases (33%). The superficial/luminal layer was negative for p63 and D2-40 in all cases. The basal layer was positive for MUC1, CK5/6, p63, and HBME-1 in all six cases (100%), for CK7 and D2-40 in two cases (33%), and for CEA in one case (17%). The basal layer was negative for MUC4, CK20, and CA19-9 in all cases. Epidermoid cysts are a characteristic feature of IPASs but not of EPASs. Immunohistochemical analysis showed that the epithelial lining of epidermoid cysts in IPASs has a mixed character of glandular, squamous, mesothelial, and urothelial epithelium.
Literatur
2.
Zurück zum Zitat Halpert B, Alden ZA (1964) Accessory spleens in or at the tail of the pancreas. A survey of 2,700 additional necropsies. Arch Pathol 77:652–654PubMed Halpert B, Alden ZA (1964) Accessory spleens in or at the tail of the pancreas. A survey of 2,700 additional necropsies. Arch Pathol 77:652–654PubMed
3.
Zurück zum Zitat Wadham BM, Adams PB, Johnson MA (1981) Incidence and location of accessory spleens. N Engl J Med 304:1111PubMed Wadham BM, Adams PB, Johnson MA (1981) Incidence and location of accessory spleens. N Engl J Med 304:1111PubMed
5.
Zurück zum Zitat Mori M, Ishii T, Iida T, Tanaka F, Takikawa H, Okinaga K (2003) Giant epithelial cyst of the accessory spleen. J Hepato-Biliary-Pancreat Surg 10:118–120 Mori M, Ishii T, Iida T, Tanaka F, Takikawa H, Okinaga K (2003) Giant epithelial cyst of the accessory spleen. J Hepato-Biliary-Pancreat Surg 10:118–120
6.
Zurück zum Zitat Adsay NV, Hasteh F, Cheng JD, Klimstra DS (2000) Squamous-lined cysts of the pancreas: lymphoepithelial cysts, dermoid cysts (teratomas), and accessory-splenic epidermoid cysts. Semin Diagn Pathol 17:56–65PubMed Adsay NV, Hasteh F, Cheng JD, Klimstra DS (2000) Squamous-lined cysts of the pancreas: lymphoepithelial cysts, dermoid cysts (teratomas), and accessory-splenic epidermoid cysts. Semin Diagn Pathol 17:56–65PubMed
8.
Zurück zum Zitat Higaki K, Jimi A, Watanabe J, Kusaba A, Kojiro M (1998) Epidermoid cyst of the spleen with CA19-9 or carcinoembryonic antigen productions: report of three cases. Am J Surg Pathol 22:704–708CrossRefPubMed Higaki K, Jimi A, Watanabe J, Kusaba A, Kojiro M (1998) Epidermoid cyst of the spleen with CA19-9 or carcinoembryonic antigen productions: report of three cases. Am J Surg Pathol 22:704–708CrossRefPubMed
9.
Zurück zum Zitat Kadota K, Kushida Y, Miyai Y, Katsuki N, Hayashi T, Bando K, Shibuya S, Haba R (2010) Epidermoid cyst in an intrapancreatic accessory spleen: three case reports and review of the literatures. Pathol Oncol Res 16:435–442. doi:10.1007/s12253-009-9229-y CrossRefPubMed Kadota K, Kushida Y, Miyai Y, Katsuki N, Hayashi T, Bando K, Shibuya S, Haba R (2010) Epidermoid cyst in an intrapancreatic accessory spleen: three case reports and review of the literatures. Pathol Oncol Res 16:435–442. doi:10.​1007/​s12253-009-9229-y CrossRefPubMed
10.
Zurück zum Zitat Schüssler M, Skoudy A, Ramaekers F, Real FX (1992) Intermediate filaments as differentiation markers of normal pancreas and pancreas cancer. Am J Pathol 140:559PubMedPubMedCentral Schüssler M, Skoudy A, Ramaekers F, Real FX (1992) Intermediate filaments as differentiation markers of normal pancreas and pancreas cancer. Am J Pathol 140:559PubMedPubMedCentral
12.
Zurück zum Zitat Reis-Filho JS, Simpson PT, Martins A, Preto A, Gartner F, Schmitt FC (2003) Distribution of p63, cytokeratins 5/6 and cytokeratin 14 in 51 normal and 400 neoplastic human tissue samples using TARP-4 multi-tumor tissue microarray. Virchows Arch 443:122–132. doi:10.1007/s00428-003-0859-2 CrossRefPubMed Reis-Filho JS, Simpson PT, Martins A, Preto A, Gartner F, Schmitt FC (2003) Distribution of p63, cytokeratins 5/6 and cytokeratin 14 in 51 normal and 400 neoplastic human tissue samples using TARP-4 multi-tumor tissue microarray. Virchows Arch 443:122–132. doi:10.​1007/​s00428-003-0859-2 CrossRefPubMed
13.
Zurück zum Zitat Plaza JA, Ortega PF, Stockman DL, Suster S (2010) Value of p63 and podoplanin (D2-40) immunoreactivity in the distinction between primary cutaneous tumors and adenocarcinomas metastatic to the skin: a clinicopathologic and immunohistochemical study of 79 cases. J Cutan Pathol 37:403–410. doi:10.1111/j.1600-0560.2010.01517.x CrossRefPubMed Plaza JA, Ortega PF, Stockman DL, Suster S (2010) Value of p63 and podoplanin (D2-40) immunoreactivity in the distinction between primary cutaneous tumors and adenocarcinomas metastatic to the skin: a clinicopathologic and immunohistochemical study of 79 cases. J Cutan Pathol 37:403–410. doi:10.​1111/​j.​1600-0560.​2010.​01517.​x CrossRefPubMed
14.
Zurück zum Zitat Cury PM, Butcher DN, Fisher C, Corrin B, Nicholson AG (2000) Value of the mesothelium-associated antibodies thrombomodulin, cytokeratin 5/6, calretinin, and CD44H in distinguishing epithelioid pleural mesothelioma from adenocarcinoma metastatic to the pleura. Mod Pathol 13:107–112. doi:10.1038/modpathol.3880018 CrossRefPubMed Cury PM, Butcher DN, Fisher C, Corrin B, Nicholson AG (2000) Value of the mesothelium-associated antibodies thrombomodulin, cytokeratin 5/6, calretinin, and CD44H in distinguishing epithelioid pleural mesothelioma from adenocarcinoma metastatic to the pleura. Mod Pathol 13:107–112. doi:10.​1038/​modpathol.​3880018 CrossRefPubMed
16.
Zurück zum Zitat Nagata K, Horinouchi M, Saitou M, Higashi M, Nomoto M, Goto M, Yonezawa S (2007) Mucin expression profile in pancreatic cancer and the precursor lesions. J Hepato-Biliary-Pancreat Surg 14:243–254. doi:10.1007/s00534-006-1169-2 CrossRef Nagata K, Horinouchi M, Saitou M, Higashi M, Nomoto M, Goto M, Yonezawa S (2007) Mucin expression profile in pancreatic cancer and the precursor lesions. J Hepato-Biliary-Pancreat Surg 14:243–254. doi:10.​1007/​s00534-006-1169-2 CrossRef
18.
Zurück zum Zitat Guillem P, Billeret V, Buisine MP, Flejou JF, Lecomte-Houcke M, Degand P, Aubert JP, Triboulet JP, Porchet N (2000) Mucin gene expression and cell differentiation in human normal, premalignant and malignant esophagus. Int J Cancer 88:856–861CrossRefPubMed Guillem P, Billeret V, Buisine MP, Flejou JF, Lecomte-Houcke M, Degand P, Aubert JP, Triboulet JP, Porchet N (2000) Mucin gene expression and cell differentiation in human normal, premalignant and malignant esophagus. Int J Cancer 88:856–861CrossRefPubMed
19.
Zurück zum Zitat Swartz MJ, Batra SK, Varshney GC, Hollingsworth MA, Yeo CJ, Cameron JL, Wilentz RE, Hruban RH, Argani P (2002) MUC4 expression increases progressively in pancreatic intraepithelial neoplasia. Am J Clin Pathol 117:791–796. doi:10.1309/7Y7N-M1WM-R0YK-M2VA CrossRefPubMed Swartz MJ, Batra SK, Varshney GC, Hollingsworth MA, Yeo CJ, Cameron JL, Wilentz RE, Hruban RH, Argani P (2002) MUC4 expression increases progressively in pancreatic intraepithelial neoplasia. Am J Clin Pathol 117:791–796. doi:10.​1309/​7Y7N-M1WM-R0YK-M2VA CrossRefPubMed
21.
Zurück zum Zitat Raval JS, Zeh HJ, Moser AJ, Lee KK, Sanders MK, Navina S, Kuan SF, Krasinskas AM (2010) Pancreatic lymphoepithelial cysts express CEA and can contain mucous cells: potential pitfalls in the preoperative diagnosis. Mod Pathol 23:1467–1476. doi:10.1038/modpathol.2010.144 CrossRefPubMed Raval JS, Zeh HJ, Moser AJ, Lee KK, Sanders MK, Navina S, Kuan SF, Krasinskas AM (2010) Pancreatic lymphoepithelial cysts express CEA and can contain mucous cells: potential pitfalls in the preoperative diagnosis. Mod Pathol 23:1467–1476. doi:10.​1038/​modpathol.​2010.​144 CrossRefPubMed
22.
Zurück zum Zitat N’Dow J, Pearson JP, Bennett MK, Neal DE, Robson CN (2000) Mucin gene expression in human urothelium and in intestinal segments transposed into the urinary tract. J Urol 164:1398–1404CrossRefPubMed N’Dow J, Pearson JP, Bennett MK, Neal DE, Robson CN (2000) Mucin gene expression in human urothelium and in intestinal segments transposed into the urinary tract. J Urol 164:1398–1404CrossRefPubMed
23.
Zurück zum Zitat Rosai J (2011) Rosai and Ackerman’s surgical pathology, vol 2, 10th edn. Elsevier Health Sciences, St. Louis Rosai J (2011) Rosai and Ackerman’s surgical pathology, vol 2, 10th edn. Elsevier Health Sciences, St. Louis
24.
Zurück zum Zitat Burrig KF (1988) Epithelial (true) splenic cysts. Pathogenesis of the mesothelial and so-called epidermoid cyst of the spleen. Am J Surg Pathol 12:275–281CrossRefPubMed Burrig KF (1988) Epithelial (true) splenic cysts. Pathogenesis of the mesothelial and so-called epidermoid cyst of the spleen. Am J Surg Pathol 12:275–281CrossRefPubMed
25.
Zurück zum Zitat Ough YD, Nash HR, Wood DA (1981) Mesothelial cysts of the spleen with squamous metaplasia. Am J Clin Pathol 76:666–669CrossRefPubMed Ough YD, Nash HR, Wood DA (1981) Mesothelial cysts of the spleen with squamous metaplasia. Am J Clin Pathol 76:666–669CrossRefPubMed
26.
Zurück zum Zitat Lifschitz-Mercer B, Open M, Kushnir I, Czernobilsky B (1994) Epidermoid cyst of the spleen: a cytokeratin profile with comparison to other squamous epithelia. Virchows Arch 424:213–216CrossRefPubMed Lifschitz-Mercer B, Open M, Kushnir I, Czernobilsky B (1994) Epidermoid cyst of the spleen: a cytokeratin profile with comparison to other squamous epithelia. Virchows Arch 424:213–216CrossRefPubMed
27.
Zurück zum Zitat Arber DA, Strickler JG, Weiss LM (1997) Splenic mesothelial cysts mimicking lymphagiomas. The Am J Surg Pathol 21:334–338CrossRefPubMed Arber DA, Strickler JG, Weiss LM (1997) Splenic mesothelial cysts mimicking lymphagiomas. The Am J Surg Pathol 21:334–338CrossRefPubMed
28.
Zurück zum Zitat Hong R, Choi N, Sun K, Lim S, Han Y (2013) Epidermoid cyst arising from an intrapancreatic accessory spleen: a case report and review of the literature. Oncol Lett 5:469–472. doi:10.3892/ol.2012.1061 PubMed Hong R, Choi N, Sun K, Lim S, Han Y (2013) Epidermoid cyst arising from an intrapancreatic accessory spleen: a case report and review of the literature. Oncol Lett 5:469–472. doi:10.​3892/​ol.​2012.​1061 PubMed
Metadaten
Titel
Epidermoid cysts are a characteristic feature of intrapancreatic but not of extrapancreatic accessory spleens
verfasst von
Kenichi Hirabayashi
Misuzu Yamada
Hirotaka Kono
Atsuko Hadano
Aya Kawanishi
Yumi Takanashi
Yoshiaki Kawaguchi
Toshio Nakagohri
Tetsuya Mine
Naoya Nakamura
Publikationsdatum
24.05.2017
Verlag
Springer Berlin Heidelberg
Erschienen in
Virchows Archiv / Ausgabe 1/2017
Print ISSN: 0945-6317
Elektronische ISSN: 1432-2307
DOI
https://doi.org/10.1007/s00428-017-2139-6

Weitere Artikel der Ausgabe 1/2017

Virchows Archiv 1/2017 Zur Ausgabe

Neu im Fachgebiet Pathologie

Open Access 15.04.2024 | Biomarker | Schwerpunkt: Next Generation Pathology

Molekularpathologische Untersuchungen im Wandel der Zeit

11.04.2024 | Pathologie | Schwerpunkt: Next Generation Pathology

Vergleichende Pathologie in der onkologischen Forschung

Open Access 08.04.2024 | GIST | CME

Gastrointestinale Stromatumoren

Wo stehen wir?

03.04.2024 | Zielgerichtete Therapie | Schwerpunkt: Next Generation Pathology

Personalisierte Medizin in der Onkologie